Search results for "Cystectomy"

showing 10 items of 175 documents

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer

2018

Background: Serum levels of neutrophils, platelets, and lymphocytes have been recognized as factors related to poor prognosis for many solid tumors, including bladder cancer (BC). Objective: To evaluate the prognostic role of the combination of the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and lymphocyte/monocyte ratio (LMR) in patients with high-risk non–muscle-invasive urothelial BC (NIMBC). Design, setting, and participants: A total of 1151 NMIBC patients who underwent first transurethral resection of the bladder tumor (TURBT) at 13 academic institutions between January 1, 2002 and December 31, 2012 were included in this analysis. The median follow-up was 48 mo.…

OncologyMaleBladder cancer; Lymphocyte/monocyte ratio; Neutrophil/lymphocyte ratio; Platelet/lymphocyte ratio; Prognosis; Aged; Biomarkers Tumor; Blood Platelets; Carcinoma Transitional Cell; Cystectomy; Disease Progression; Female; Follow-Up Studies; Humans; Inflammation; Lymphocyte Count; Lymphocytes; Male; Monocytes; Neutrophils; Prognosis; Risk Factors; Urinary Bladder NeoplasmsNeutrophilsmedicine.medical_treatmentLymphocyte:Medicina Básica [Ciências Médicas]Prognosis.030232 urology & nephrologyMonocyteMonocytesSettore MED/24 - Urologia0302 clinical medicineRisk FactorsLymphocytesStage (cooking)Framingham Risk ScoreTumorNeutrophilBladder cancerPrognosis3. Good healthmedicine.anatomical_structureOncology030220 oncology & carcinogenesisNeutrophil/lymphocyte ratioCiências Médicas::Medicina BásicaDisease ProgressionLymphocyteFemalemedicine.symptomHumanBlood Plateletsmedicine.medical_specialtyPlatelet/lymphocyte ratioPrognosiUrologyInflammationCystectomyFollow-Up StudieCystectomy03 medical and health sciencesInternal medicinemedicineBiomarkers TumorHumansRadiology Nuclear Medicine and imagingLymphocyte CountAgedInflammationCarcinoma Transitional CellBladder cancerScience & Technologybusiness.industryProportional hazards modelRisk FactorCarcinomaLymphocyte/monocyte ratioImmunotherapymedicine.diseaseUrinary Bladder NeoplasmsBlood PlateletSurgeryTransitional CellbusinessBiomarkersFollow-Up Studies
researchProduct

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a …

2014

Contains fulltext : 153742.pdf (Publisher’s version ) (Closed access) BACKGROUND: The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critical for proper treatment decision making. OBJECTIVE: To assess prognostic factors in patients who received bacillus Calmette-Guerin (BCG) as initial intravesical treatment of T1G3 tumors and to identify a subgroup of high-risk patients who should be considered for more aggressive treatment. DESIGN, SETTING, AND PARTICIPANTS: Individual patient data were collected for 2451 T1G3 patients from 23 centers who received BCG between 1990 and 2011. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Using Cox multivariable re…

OncologyMaleNon–muscle-invasive bladderBacillus Calmette-Guerin; BCG; Non-muscle-invasive bladder cancer; Prognostic factors; T1G3Settore MED/24 - UrologiaRisk groupsRetrospective StudieRisk FactorsBCGAge Factorskin and connective tissue diseasesBacillus Calmette-GuerinBacillus (shape)Prognostic factorbiologyBacillus Calmette-Gue´rin BCG Non–muscle-invasive bladder cancer Prognostic factors T1G3Age FactorsBacillus Calmette-Gue´rinMiddle AgedPrognosisTumor BurdenBacilluSurvival RateUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]Urinary Bladder NeoplasmBCG VaccineDisease ProgressionFemaleNon muscle invasiveCalmette-GuérinCarcinoma in SituHumanmedicine.medical_specialtyPrognosiNon-muscle-invasive bladder cancerUrologyUrologyT1G3Prognostic factorsCystectomyRisk AssessmentNon–muscle-invasive bladder cancerFollow-Up StudieAdjuvants ImmunologicInternal medicineUrological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15]medicinecancerHumansAgedRetrospective StudiesBladder cancerbusiness.industryRisk Factorbiology.organism_classificationmedicine.diseaseMulticenter studyUrinary Bladder NeoplasmsProper treatmentNeoplasm Recurrence LocalbusinessFollow-Up StudiesEuropean urology
researchProduct

Orthotopic MAINZ pouch bladder substitution – long-term follow-up

2021

Introduction After radical cystectomy, orthotopic neobladder is one surgical strategy for urinary diversion. To assess the usefulness of an operation, long-term data are essential. We examined long-term complications and continence rates of orthotopic ileocecal (MAINZ pouch) bladder substitution. Material and methods Between 1986 and 2011, 193 patients underwent orthotopic MAINZ pouch bladder substitution. Until July 2000, ureter implantation was performed into the ascending colon through a submucosal tunnel technique (Goodwin-Hohenfellner). After July 2000, ureters were implanted into the terminal Ileum using the ileocecal valve to prevent reflux: the left spatulated ureter by an end-to-en…

Original PaperStress incontinencemedicine.medical_specialtyBladder cancerbusiness.industrymedicine.medical_treatmentUrinary diversionGeneral Medicineorthotopic bladder substitutionlong-term resultsmedicine.diseaseSurgeryCystectomyIleocecal valvemedicine.anatomical_structureUreterurinary diversionbladder cancerMedicineAscending colonPouchbusinessCentral European Journal of Urology
researchProduct

Automated DNA-image cytometry: a prognostic tool in infiltrating bladder carcinoma?

1987

In a retrospective study, paraffin-embedded cystectomy specimens obtained from 46 patients with bladder cancer (stage pT1 — pT4a, pN0, pN2) were analysed for tumor DNA ploidy and proliferation using automated image cytometry (LEYTAS). In 41 cases, DNA ploidy could be measured. Estimation of proliferation was possible in 26 tumors. The number of cells with a DNA content higher than 5C could be calculated in 38 of the tumors. All these three parameters are shown to correlate with patient outcome.

Pathologymedicine.medical_specialtyBladder cancerUrinary bladderbusiness.industryUrologymedicine.medical_treatmentmedicine.diseaseCystectomychemistry.chemical_compoundmedicine.anatomical_structurechemistryCarcinomamedicineStage (cooking)businessCytometryDNADNA Image CytometryWorld Journal of Urology
researchProduct

DNA Histogram of Invasive Bladder Carcinoma: Comparison of Flow Cytometry and Automated Image Analysis

1989

Invasive bladder carcinoma is characterized by a considerable interindividual heterogeneity. The natural course of the disease as well as sensitivity of the tumors to various treatment modalities are thus unpredictable. Searching for more accurate characteristics of tumor biology than those presently available, the DNA histograms of 65 paraffin-preserved bladder carcinomas from cystectomy specimens were analyzed. Flow cytometry and automated image analysis, two competing methods, were compared.

Pathologymedicine.medical_specialtyNatural coursemedicine.diagnostic_testTumor biologybusiness.industrymedicine.medical_treatmentmedicine.diseaseFlow cytometryCystectomychemistry.chemical_compoundchemistryHistogrammedicineCarcinomaImage CytometrybusinessDNA
researchProduct

Sarcomatoid carcinoma of urinary bladder: Immunohistochemical study of an uncommon case

2002

A case of sarcomatoid carcinoma of the bladder is reported herein. Immunohistochemical staining with human pancytokeratin antibody was negative, while vimentin staining was strongly positive, suggesting a diagnosis of sarcoma of the bladder. Further immunohistochemical analysis revealed positivity for AE1/AE3 cytokeratins, permitting a correct diagnosis of sarcomatoid carcinoma of the bladder. It can be difficult to distinguish between sarcomatoid carcinoma, undifferentiated carcinoma and sarcoma, particularly if the biopsy specimens are of small size. In rare cases, sarcomatoid tumors may express epithelial markers different from those revealed by human pancytokeratin staining. Copyright ©…

Pathologymedicine.medical_specialtyUrinary bladder tumorAE1/AE3 cytokeratinmedicine.medical_treatmentUrologyVimentinSarcomatoid carcinomaCystectomyCytokeratinBiopsyHumansMedicineSarcomatoid carcinomaAgedUrinary bladderbiologymedicine.diagnostic_testAE1/AE3 cytokeratins; Human pancytokeratin; Sarcomatoid carcinoma; Urinary bladder tumors; Urologybusiness.industryCarcinomaSarcomamedicine.diseaseImmunohistochemistrymedicine.anatomical_structureUrinary Bladder NeoplasmsHuman pancytokeratinbiology.proteinKeratinsFemaleSarcomabusinessSpindle cell carcinoma
researchProduct

Concomitant Small Cell Neuroendocrine Carcinoma of Gallbladder and Breast Cancer

2014

The neuroendocrine carcinoma is defined as a high-grade malignant neuroendocrine neoplasm arising from enterochromaffin cells, usually disposed in the mucosa of gastric and respiratory tracts. The localization in the gallbladder is rare. Knowledge of these gallbladder tumors is limited and based on isolated case reports. We describe a case of an incidental finding of small cell neuroendocrine carcinoma of the gallbladder, observed after cholecystectomy for cholelithiasis, in a 55-year-old female, who already underwent quadrantectomy and sentinel lymph-node biopsy for breast cancer. The patient underwent radiotherapy for breast cancer and six cycles of chemotherapy with cisplatin and etoposi…

Pathologymedicine.medical_specialtybusiness.industryGallbladdermedicine.medical_treatmentlcsh:SurgeryCase Reportlcsh:RD1-811Settore MED/08 - Anatomia PatologicaMalignancymedicine.diseaseRadiation therapySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureBreast cancerNeuroendocrine carcinomamedicineEnterochromaffin cellPharmacology (medical)CholecystectomyNeoplastic transformationbusinessQuadrantectomy
researchProduct

Tonnenkonkremente im Ductus choledochus bei einer 4 Jahre vergessenen, impaktierten Endoprothese

2006

We report on a 67-year-old female patient who presented in July 2005 with sudden onset of pain in the right upper abdomen. The patient had undergone cholecystectomy in 1987. Because of recurrrent complaints in the right upper abdomen, a pigtail stent was placed into the common hepatic duct in 2001. When the patients presented now, the laboratory tests including liver enzymes were within normal ranges. Endoscopic retrograde cholangiogi aphy, however, revealed a remaining 10-French, impacted double pigtail endoprothesis that was obstructed by sludge as well as multiple giant bile duct stones of 20 to 30 mm in size. The giant stones could be finally removed by the combined use of ESWL and endo…

Pigtailmedicine.medical_specialtyBile ductbusiness.industrymedicine.medical_treatmentCombined useGastroenterologyStentSurgerymedicine.anatomical_structureCommon hepatic ductFemale patientmedicineCholecystectomybusinessSudden onsetZeitschrift für Gastroenterologie
researchProduct

Chronic asthenia in patients who have undergone endocrine neck surgery.

2021

Introduction: The impact of chronic asthenia after thyroidectomy has been evaluated in two previous studies comparing total thyroidectomy and hemithyroidectomy. We compared its impact on patients undergoing thyroidectomy, parathyroidectomy for primary hyperparathyroidism, and cholecystectomy. Methods: Patients recruited for surgery (233 consecutive total thyroidectomies for non-toxic multinodular goiter, Group I, 43 consecutive parathyroidectomies for primary hyperparathyroidism, group II and a sample of 43 laparoscopic cholecystectomies, group III) were compared at three times: pre-operative, 6 months after surgery, 1 year after surgery. A brief fatigue inventory (BFI) was administered to …

Quality of lifeParathyroidectomymedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTertiary hyperparathyroidismEndocrinologyDiabetes mellitusmedicineHumansThyroid NeoplasmsDepression (differential diagnoses)Retrospective StudiesParathyroidectomybusiness.industryThyroidectomySequelamedicine.diseaseSurgeryAstheniaThyroidectomyCholecystectomybusinessPrimary hyperparathyroidismNeckEndocrine
researchProduct

Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors

2012

Purpose: Women undergoing radical cystectomy (RC) and urinary diversion for bladder cancer experience substantial limitations in health-related quality of life (HRQOL). However, the level of discomfort caused by different urinary diversion has been never evaluated in long term survivors. The aim of this multicenter study is to evaluate differences in HRQOL among recurrence-free women undergoing cutaneous ureterostomy (CUS), Bricker's ileal conduit (BK-IC) and Orthotopic neobladder VIP (ONB-VIP) in disease-free females treated with radical cystectomy (RC), with long-term follow up (mean 60.1 months; range 36-122 months). Materials and methods: All consecutively treated female patients from t…

Quality of lifemedicine.medical_specialtyTime FactorsTime Factormedicine.medical_treatmentUrologyDisease freeUrinary DiversionCystectomyUreterostomyCystectomyQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansSurveys and QuestionnaireSurvivorsOrthotopic urinary reservoirUreterostomyAgedAged 80 and overBladder cancerbusiness.industryResearchBladder cancerUrinary Reservoirs ContinentUrinary diversionPublic Health Environmental and Occupational HealthCancerOrthotopic urinary reservoirsGeneral MedicineMiddle Agedmedicine.diseasehumanitiesUrinary Bladder Neoplasmsradical cystectomy; Quality of lifeMulticenter studyBladder cancer; Orthotopic urinary reservoirs; Quality of life; Urinary diversionUrinary Bladder NeoplasmFemaleSurvivorbusinessUrinary diversion; Orthotopic urinary reservoirs; Bladder cancer; Quality of lifeHumanHealth and Quality of Life Outcomes
researchProduct